id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0245-0009,FDA,FDA-2011-E-0245,Letter from U.S. Patent and Trademark Office to Foley & Lardner LLP,Other,Letter(s),2015-02-24T05:00:00Z,2015,2,2015-02-24T05:00:00Z,,2015-02-24T18:16:34Z,,0,0,0900006481a12785